Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) Short Interest Up 260.9% in June

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) was the target of a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 208,401 shares, an increase of 260.9% from the May 31st total of 57,741 shares. Approximately 1.9% of the shares of the company are short sold. Based on an average daily volume of 1,239,748 shares, the short-interest ratio is currently 0.2 days.

Institutional Trading of Hong Kong Pharma Digital Technology

An institutional investor recently bought a new stake in Hong Kong Pharma Digital Technology stock. StoneX Group Inc. acquired a new position in shares of Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ:HKPD) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 43,284 shares of the company’s stock, valued at approximately $36,000. StoneX Group Inc. owned approximately 0.39% of Hong Kong Pharma Digital Technology at the end of the most recent reporting period.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Hong Kong Pharma Digital Technology in a research note on Friday, May 1st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Hong Kong Pharma Digital Technology has an average rating of “Sell”.

Hong Kong Pharma Digital Technology Trading Down 2.7%

Shares of HKPD stock traded down $0.01 during trading hours on Friday, hitting $0.36. The company had a trading volume of 14,700 shares, compared to its average volume of 760,880. Hong Kong Pharma Digital Technology has a 12 month low of $0.32 and a 12 month high of $2.58. The company has a current ratio of 2.93, a quick ratio of 2.73 and a debt-to-equity ratio of 0.28. The firm’s fifty day moving average is $0.54 and its 200 day moving average is $0.66.

About Hong Kong Pharma Digital Technology

Hong Kong Pharma is an exempted limited liability company formed under the laws of the Cayman Islands on August 17, 2023. As a holding company with no material operations of its own, Hong Kong Pharma conducts its operations through its wholly owned subsidiaries, Joint Cross Border Logistics Company Limited and V-Alliance Technology Supplies Limited, each a limited liability corporation incorporated in Hong Kong and collectively referred to as HK Subsidiaries. Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division.